↓ Skip to main content

Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis

Overview of attention for article published in International Journal of Pharmaceutics, September 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

patent
1 patent

Readers on

mendeley
65 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis
Published in
International Journal of Pharmaceutics, September 2019
DOI 10.1016/j.ijpharm.2019.118689
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 65 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 12 18%
Student > Bachelor 7 11%
Student > Master 5 8%
Researcher 4 6%
Other 3 5%
Other 7 11%
Unknown 27 42%
Readers by discipline
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 14 22%
Medicine and Dentistry 5 8%
Nursing and Health Professions 3 5%
Immunology and Microbiology 3 5%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 6 9%
Unknown 32 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2023.
All research outputs
#8,540,769
of 25,385,509 outputs
Outputs from International Journal of Pharmaceutics
#2,611
of 8,192 outputs
Outputs of similar age
#141,630
of 351,707 outputs
Outputs of similar age from International Journal of Pharmaceutics
#14
of 57 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,192 research outputs from this source. They receive a mean Attention Score of 4.4. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,707 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.